0: Pre-implementation (May 2023) |
Trial implementation |
Pilot implementation conducted: November 2022 |
Use of unique identifiers (ID, image-based) for participants trialled but not considered user-friendly by participants or for health information system
Trialled screening with Daru Provincial Hospital (DPH) staff households but low uptake
|
|
Test tools and process in trial implementation |
Version 1 of tools and SOP used in trial implementation |
|
Full household mapping planned.
Updated SOP and tools
Updated database for data capturing (Bahmni)
Revised and documented screening flow in SOP
|
Team recruitment, training, and orientation |
33 new staff recruited, total SWEEP-TB staff (n = 45); SWEEP-TB staff trained and orientated |
Staff assessed after training and orientation for sub-team allocation as per organogram |
Allocated in sub-teams to focus on specific activities/tasks |
Staff screening in preparation for full implementation in the community |
57 staff screened in May 2023 |
Revised process and tools with team |
|
1: Start implementation (1 June–22 August 2023) |
Full implementation by ward: sequence: Ward 1 > Ward 2 > Ward 3 > Ward 4 |
Ward 1:
Community engagement resumed on 10 May 2023
Household mapping commenced on 10 May 2023
Community screening commenced on 13 June 2023
|
Mismatch, 3 screening teams vs. 1 clinical team
Slow screening pace, projected to not reach targets
Discrepancies in Screening & Diagnostic Form identified
Data entry to the EMRS lagging – being done at the office and not field
Stock out of drugs (isoniazid 100 mg) and consumables (Xpert Ultra cartridges)
PPD cold-chain breach
Security threat: team verbally assaulted/ threatened during community awareness and mapping activities
|
Reassess staffing requirements to increase clinical teams - TB fellows recruited and planned for additional HEO and CHWs
Monitoring screening reports of the number screened and refused per team. Increased screening frequency from 3 days/week to 5 days/week
Explore options for increasing data entry pace: field data entry through a VPN connection; explore hiring additional DEOs, and bi-weekly data cleaning reports for data and screening/clinical teams
Close monitoring of drugs and consumables stock through the hospital and consider a backup plan/parallel system for drugs and consumables
CAG/community leaders/community reps to be involved in the initial week of screening at a new location to encourage community participation and mitigate security risks
|
2: Implementation (23 August–7 November 2023) |
Progress implementation with recommended actions from Cycle 1 |
Continued screening and TPT in Ward 1 |
CAG provided feedback on community education and engagement materials, including consent
Main challenges were with CXR and CAD4TB connections, PPD stockouts, and duplicate screening
Challenges with the referral pathway and links with TBDC
SWEEP-TB staffing complement still not optimum, impacting operations at the screening station
Data entry still lagging with data quality concerns
Staff wellbeing at community/screening site concerns
|
Human resources:
TB Fellows x2 commenced and rotated to support SWEEP-TB
2x CHW replacements recruited to fill vacancies from resignations
Mapping team absorbed into screening/clinical team to increase HR capacity
Additional data entry officer recruited
Data:CXR:Staff wellbeing:
Trailer for storage and mobilisation of current mobile CXR machine with generator set
Bicycles for participant follow-ups in the community
Temporary screening and TPT shelters to supplement gazebos
Staff toilet, wash and break station
|
3: Implementation (8 November–15 December 2023) |
Continue and progress implementation with recommended actions from Cycle 2 |
Progressed screening in Ward 1 |
Main challenges included TPT drug (levofloxacin) shortage resulting in treatment interruptions and increased backlog of pending initiations, and screening delays or disruptions due to numerous factors, e.g. lack of communication or coordination across other teams
Persisting challenges were lag in data entries, prolonged waiting time at screening stations as the number screened increased, delays in screening site preparations
Other challenges included duplicate screening, increase in the number of participants pending screening outcome, incorrect nutritional assessment, gaps in routine TPT referral, and concerns for confidentiality
|
Escalated issue of levofloxacin shortage for decisions on the way forward for both supply and patient care.
Raised issue of poor communication or coordination with respective teams concerned to prevent/mitigate delays or disruptions in screening
Strengthen weekly follow-up and monthly data cleaning days to clear backlogs of screening outcome pending and EMRS data entry
Plan for refresher training on gaps identified or areas to improve, meanwhile conduct on-the-job training/refreshers for nutritional assessment, routine TPT referrals, and maintaining confidentiality of participants
Identified options to mitigate duplicate screening
|